We also found that AIM2 was highly methylated in patients with high-risk osteosarcoma and was expressed lower in metastatic osteosarcoma cells, which was consistent with the point that loss of AIM2 promotes cancer metastasis (40, 41). The gene discussed is AIM2; the disease is osteosarcoma.